Middle Molecule Find

Rulebook › V-tags › V276

V276 Preconfigured HD systems in-center: follow FDA labeling

Written V0276 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.40(e) · Appendix H Rev. 246, page 127 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.40(e) - In-center use of preconfigured hemodialysis system. When using a preconfigured, FDA-approved hemodialysis system designed, tested and validated to yield AAMI quality (which includes standards for chemical and chlorine/chloramine testing) water and dialysate, the system’s FDA-approved labeling must be adhered to for machine use and monitoring of the water and dialysate quality…

Read 42 CFR 494.40 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.40(e)

At the time of publishing these regulations (April 15, 2008, 73FR20369), several different preconfigured hemodialysis systems were available. These included conventional water treatment components and single-pass (conventional) dialysis machines; integrated systems which incorporated water treatment and dialysate preparation and delivery into one system; and sorbent-based systems which utilized columns (cartridges) of chemicals to regenerate the used dialysate for recirculation through the dialyzer. Although primarily used for home therapies, a preconfigured hemodialysis system may be used in-center. Such use might be for training a home patient, for back-up treatment of home patients, or for routine in-center treatment. In all cases, the system’s FDA-approved labeling must be followed for machine use and monitoring of the water and dialysate quality.

Following the rationale established in AAMI 4.1: Water and 6.2.7 for achieving product water quality, if the preconfigured hemodialysis system incorporates a water treatment system, analysis of the water quality must be performed to ensure contaminants do not exceed maximum level of chemical contaminants listed at AAMI 4.1.1 (Table 1). A chemical analysis of the product water must be done at least annually near the end of the usability of any disposable component, or when any modifications are made to the treatment components (other than the replacement of disposable components). When any repairs are made to water treatment equipment, the impact on water quality should be evaluated and a chemical analysis performed if the repairs resulted in any modifications to the treatment components.

Chlorine/chloramine levels must be tested prior to the start of each treatment (or before use of each new batch of dialysate) in accordance with AAMI guidance and the manufacturer’s recommendations/instructions for that test method. An appropriate volume of water for the testing method in use should be tested for the presence of chlorine/chloramine. The minimum volume of water required for testing is typically specified by the manufacturer or laboratory conducting the test. For batch systems (integrated systems which prepare enough dialysate for multiple treatments), the chlorine/chloramine testing must be performed at the worst case scenario, i.e., after the preparation of each batch of dialysate, but before use of that batch. If the test results exceed AAMI’s maximum allowable level, the user must discard the batch, replace any applicable components, prepare a new batch of dialysate, and retest.

Systems that use sorbent technology do not produce water; the product of the sorbent cartridge is dialysate, thus, the requirements for the chemical, bacteriological and endotoxin testing of water do not apply. With sorbent technology, due to the low volume of exposure of patients to water (i.e., 6 liters per treatment) and the capacity of the single use sorbent cartridge to remove chlorine and chloramine, testing for chlorines and chloramine is not required. Sorbent system users are expected to perform bacteriological and endotoxin testing on dialysate.

Monitoring of the system must be in accordance with the FDA-approved labeling, which includes the manufacturers' directions for use (DFU). The facility should have the manufacturers' DFUs on file, and facility procedures should reflect those DFUs.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 127 (the full 469-page PDF) before quoting it.

Connected tags

Tags whose guidance points here